Chinese Polyresistin Industry Canvassed by CRI in Comprehensive Market Research Report Available at MarketPublishers.com09 Mar 2016 • by Natalie Aster
LONDON – Polyresistin refers to a type of polysaccharides obtained from hemolytic streptococcus during fermentation. Polyresistin is mainly used for the treatment of leucopenia and aplastic anemia; for preventing immune dysfunction triggered by various infections; with different types of cancer, chemotherapy, radiotherapy or adjuvant therapy after surgery, radiation injury prevention; in the meantime, with this product in septic allergic arthritis, recurrent respiratory tract infections, treatment of peptic ulcer, atrophic gastritis, cervical ectropion, oral mucosal Oral lesions and similar.
The past few years have seen a dramatic increase in polyresistin sales in China. In value terms, they reached close to USD 38.4 million in 2016 from around USD 10.75 million in 2014, registering a 17.7% CAGR.
With the aggravation of environmental contamination in China, along with lifestyle changes caused by economic growth, China is poised to have a surging incidence rates of cancer, respiratory tract infections in the offing, which will likely contributes to the enlargement of the polyresistin market size.
Sinopham A-Think Pharmaceutical Co., Ltd., Chengdu Li’er Pharmaceutical Co., Ltd., Sichuan Aobang Pharmaceutical Co., Ltd., Guangdong Winnerway Pharmaceutical Co., Ltd., and Pearl Ocean Pharmaceutical Holdings, Ltd. are the prominent players in the national polyresistin marketplace.
Comprehensive market research report “Market Research Report on Polyresistin in China, 2010-2019” elaborated by China Research and Intelligence (CRI) provides deep insights into the Chinese polyresistin sector.
The study gives an overview of the country’s polyresistin market, covering patent status and approval information pertaining to polyresistin in China, market sizing, key producers. It discusses the sales status of polyresistin in the country during 2010-2014, examining sales value and volume across the whole country and region-wise. The research report uncovers data on the market share of the major domestic polyresistin manufacturers by sales value and sales volume. It covers the dosage shares, by value and volume, of polyresistin in the country cover the period from 2010 to 2014. The report presents an overview of the sales prices of polyresistin made by various enterprises across; and also limelights the competition landscape and profiles the top market players. Additionally, the report provides the outlook of the Chinese polyresistin market in terms of market size and competitive scenario.
Market Research Report on Polyresistin in China, 2010-2019
Published: February, 2016
Price: US$ 2,000.00
More comprehensive market research reports by the publisher can be found at CRI page.